News

DBV Technologies S.A. Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Peanut ...
I n a significant blow to Pakistan’s military, the Baloch Liberation Army (BLA) has claimed responsibility for a deadly IED blast in Bolan Darra, Balochistan, killing 12 Pakistani soldiers ...
Findings from HERTHENA-Lung02 showed that the key secondary endpoint of overall survival did not meet statistical significance. Daiichi Sankyo and Merck have voluntarily withdrawn the Biologics ...
New Delhi: The Balochistan Liberation Army, also known as the Baloch Liberation Army (BLA), has been in the news for about a year due to its audacious attacks deep inside Pakistan which are being ...
The Baloch Liberation Army (BLA) has taken complete control of Surab city of Pakistan, news agency ANI has reported. The BLA, as part of a large-scale armed operation, has also targeted state ...
FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date Omeros Corporation ...
The Company plans to resubmit the BLA later this year, after vaccine efficacy data from the ongoing Phase 3 trial of its investigational seasonal influenza vaccine, mRNA-1010, are available.
Patritumab deruxtecan's BLA withdrawal was due to HERTHENA-Lung02 trial's unsatisfactory overall survival results, despite progression-free survival significance. The HERTHENA-Lung02 trial compared ...
(RTTNews) - REGENXBIO Inc. (RGNX) Tuesday said that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RGX-121 for the treatment of ...
Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA) for ...